http://www.biospace.comBioSpace RSS GeneratorFri, 24 May 2013 19:23:59 GMT20http://rss.biospace.com/images/BSPLogo.gifhttp://www.BioSpace.com/news.aspx?SectionId=1Copyright (C) 2011http://www.biospace.com/news_story.aspx?StoryID=292508&full=1RUTHERFORD, N.J.--(BUSINESS WIRE)-- Cancer Genetics, Inc., a diagnostics company focused on developing genomic-based, oncology tests and services, today announced the pricing of its initial public offering of 600,000 shares of its common stock at a price to the public of $10.00 per share. The gross proceeds to Cancer Genetics from the initial public offering are expected to be $6,000,000 (assuming...Fri, 05 Apr 2013 12:00:00 AM GMTRALEIGH, N.C. LipoScience, Inc.(NASDAQ: LPDX) today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a price to the public of $9.00 per share. The shares are expected to begin trading on The NASDAQ Global Market under the ticker symbol "LPDX" on Friday, January 25, 2013. All of the shares are being offered by LipoScience. In addition, LipoScience has granted...Fri, 25 Jan 2013 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=279908&full=1<div id"releaseBody"><p>SEATTLE, WA--(Marketwire - November 14, 2012) - Atossa Genetics, Inc. (NASDAQ: <a href"http://www.marketwire.com/mw/stock.jsp?TickerATOS">ATOS</a>) announced today the closing of its initial public offering of 800,000 shares of its common stock at an initial public offering price of $5.00 per share. Atossa Genetics' common stock is traded on the NASDAQ Capital Market under...Thu, 15 Nov 2012 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=278917&full=1<div id"releaseBody"><p>SEATTLE, WA--(Marketwire - November 08, 2012) - Atossa Genetics, Inc. (NASDAQ: <a href"http://www.marketwire.com/mw/stock.jsp?TickerATOS">ATOS</a>) (the "Company") announced today the pricing of its firm commitment, underwritten initial public offering of 800,000 shares of its common stock at a price of $5.00 per share. In addition, the underwriters were granted a 45...Thu, 08 Nov 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20120906_1by Richard Daverman, PhD</p><p>September 6, 2012 -- China National Biotec Group, a unit of China's sprawling state-owned pharmaceutical giant, Sinopharm Group, will seek to raise up to 10 billion RMB ($1.6 billion) in a Hong Kong IPO. The company was given an OK to stage its previously announced IPO by Hong Kongs environment ministry today. It still needs the blessing of the China Securities Regulatory...Thu, 06 Sep 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20120803005302&newsLang=enAUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced the pricing of its initial public offering of 8,333,333 shares of Class A common stock at a price of $12 per share, consisting of 2,083,333 shares offered by Globus Medical and 6,250,000 shares offered by selling stockholders. In addition, Globus Medical has granted the underwriters...Fri, 03 Aug 2012 12:00:00 AM GMThttp://seekingalpha.com/article/773551-can-globus-medical-s-ipo-compete-with-already-public-rivalsGlobus Medical (GMED) is set to go public this week on the New York Stock Exchange. The company calls itself the "world's largest private spine company". The company has key competitors and will definitely not be the biggest spine company on the public exchanges when they do complete their IPO. Globus Medical is a medical device maker for spine disorders. The company competes with large rivals Stryker...Thu, 02 Aug 2012 12:00:00 AM GMThttp://www.bizjournals.com/southflorida/news/2012/06/11/aurora-diagnostics-cancels-ipo-plans.html?ana=otjrssAurora Diagnostics has canceled its long-delayed plans for an IPO. The Palm Beach Gardens-based diagnostics services company filed IPO documents with the U.S. Securities and Exchange Commission in April 2010, seeking to raise up to $150 million. Although it never set a date or price for that offering, the company updated its financial results every quarter to keep its eligibility for the offering...Tue, 12 Jun 2012 12:00:00 AM GMThttp://www.bizjournals.com/philadelphia/blog/john-george/2012/05/globus-of-audobon-increases-ipo-goal.html?ana=otjPhiladelphia Business Journal by John George, Senior Reporter </p><p>Globus Medical bumped up the maximum amount it is seeking to raise through an initial public stock offering to $150 million from $100 million, according to documents filed with the Securities and Exchange Commission this month.</p><p>The Audubon, Pa., medical-device company, which specializes in products used in spinal surgery...Thu, 31 May 2012 12:00:00 AM GMThttp://www.chinabiotoday.com/articles/20120515May 14, 2012 -- Ningbo David Medical Device Co. completed its IPO on the ChiNext Exchange on May 7, raising 400 million RMB ($63.5 million). The company placed 20 million shares at a price of 20 RMB each, a price/earnings ratio of 30. After rising to a high of 30 RMB, the stock closed today at 26.13 RMB, a return of 31% for the IPO investors. David Medical Device produces infant warmers and products...Tue, 15 May 2012 12:00:00 AM GMThttp://www.theaustralian.com.au/business/breaking-news/osprey-medical-set-to-list-on-asx/story-e6frg90f-1226330169498? Osprey Medical is a late stage medical device company with products designed to reduce kidney injury from x-ray dyes used during common heart procedures such as stenting and angioplasty. <br>? Osprey Medicals lead product, the CINCORTM System, has received approval to conduct a registration directed pivotal trial from the US FDA which is planned to start in 2012. <br>? The CINCORTM System...Tue, 17 Apr 2012 12:00:00 AM GMThttp://www.lifescientist.com.au/article/417904/osprey_medical_raise_20m_ipo/EDEN PRAIRIE, Minn. & SYDNEY--(BUSINESS WIRE)-- Osprey Medical Inc, has today announced its plans to raise A$20 million through an underwritten Initial Public Offer (IPO) and has applied to list on the Australian Securities Exchange (ASX). </p><p>Osprey Medical is a late stage medical device company and its lead product, the CINCORTM System is used in angioplasty and stenting procedures to remove...Thu, 08 Mar 2012 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace2/template.PAGE/menuitem.ce58e8202d51f40bfcb16f10c0908a0c/index.jsp?ndmViewId=news_view&newsId=20111230005186&newsLang=enROCHESTER, N.Y.--(BUSINESS WIRE)--Lucid, Inc. (OTCBB: LCDCU) today announced that it has closed its previously announced underwritten public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock. Net proceeds received by Lucid were approximately $5.30 million, after deducting the underwriting discount and corporate...Tue, 03 Jan 2012 12:00:00 AM GMThttp://www.jsonline.com/business/exact-sciences-to-sell-31-million-shares-jr3b79m-135099633.htmlMADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Robert W. Baird & Co. Incorporated is acting as sole book-running manager in the offering and William Blair & Company is acting as co-manager for the offering. The offering is subject to market conditions, and there can...Fri, 09 Dec 2011 12:00:00 AM GMThttp://topics.scmp.com/news/china-business-watch/article/Biotech-firm-seeks-HK282m-in-IPOBiotechnology company LifeTech Scientific Corp aims to raise up to HK$282.5 million through an initial public offering on the second board today to fund new manufacturing and product development. The Shenzhen-based company, which specialises in implants for treating cardiovascular disorders, will offer 125 million shares at a target price of between HK$1.91 and HK$2.26 each. LifeTech has earmarked...Mon, 31 Oct 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=216614&full=1MISGAV, ISRAEL and VIENNA, VA--(Marketwire - 04/08/11) - Medgenics, Inc. (AMEX:MDGN - News) (AMEX:MDGN.W - News) (AIM: MEDG) (AIM: MEDU), the company that has developed a novel technology for the sustained manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, today announced the pricing of its initial underwritten public offering in the United States of ...Fri, 08 Apr 2011 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=205823&full=1SAN DIEGO and SYDNEY, Australia, Dec. 21, 2010 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA - News) ("REVA" or the "Company") is pleased to announce that its Initial Public Offering (the Offer) has closed and that the Company has raised A$85,000,003.<p></p>The Lead Manager to the Offer was boutique Sydney based Investment Bank, Inteq Limited. Southern Cross Securities Limited and Taylor Collison...Wed, 22 Dec 2010 12:00:00 AM GMThttp://www.reuters.com/article/idUSN1017598620100811Wall Street Journal -- Medical-device maker China Kanghui Holdings' initial public offering of at least 6.7 million American depositary shares priced at $10.25 Tuesday, in the middle of the expected price range of $9.25 to $11.25. Wed, 11 Aug 2010 12:00:00 AM GMThttp://www.forbes.com/feeds/ap/2010/08/05/business-health-care-us-d-medical-ipo-priced_7827200.htmlTIRAT CARMEL, ISRAEL--(Marketwire - 08/05/10) - D. Medical Industries Ltd., a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today the initial public offering in the United States of 1,500,906 of its ordinary shares at a price of US$7.00 per share. Prior to the initial...Thu, 05 Aug 2010 12:00:00 AM GMThttp://www.renaissancecapital.com/ipohome/news/D.-Medical-decreases-proposed-IPO-deal-size-8335.htmlRenaissance Capital -- D. Medical, a medical device company that develops and manufactures insulin pumps, lowered the proposed deal size for its upcoming IPO on Tuesday. The Israel-based company now plans to raise $21 million by offering 1.88 million shares at a price range of $10-$12 after previously filing to offer 2.73 million shares. At the mid-point of the revised range, D. Medical will raise...Tue, 03 Aug 2010 12:00:00 AM GMThttp://online.wsj.com/article/BT-CO-20100628-712797.htmlWSJ -- SurgiVision Inc. said it plans to sell 2.5 million shares of its common stock at between $13 and $15 a share in its planned initial public offering, as it begins marketing its first medical device after receiving the Food and Drug Administration's go-ahead. Wed, 30 Jun 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=183080&full=1PETACH-TIKVA, ISRAEL--(Marketwire - 06/07/10) - Aposense, a world leader in developing diagnostic and therapeutic drugs based on targeting in vivo apoptosis (programmed cell death), today announced the successful completion of the company's Initial Public Offering in the Israeli market. The company's shares will be listed on the Tel Aviv Stock Exchange (TASE) and trade under the symbol APOS beginning...Wed, 16 Jun 2010 12:00:00 AM GMThttp://www.biospace.com/news_story.aspx?StoryID=182317&full=1SAN DIEGO--(BUSINESS WIRE)--GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. The shares are expected to begin trading today on the NASDAQ Global Market under the ticker symbol GNMK. In addition, GenMark has granted the underwriters...Tue, 01 Jun 2010 12:00:00 AM GMThttp://www.pehub.com/69738/dynavox-prices-low-ipo/Pehub -- DynaVox Inc., a Pittsburgh-based maker of software and devices that assist people in overcoming speech, raised around $140.6 million via its IPO. The company sold nearly 9.4 million shares at $15 per share (low end of $15-$17 range).Thu, 22 Apr 2010 12:00:00 AM GMThttp://finance.yahoo.com/news/Dehaier-Medical-Systems-prnews-719656393.html?x=0&.v=12BEIJING, April 22 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM - News), an emerging leader in the development, assembly, marketing and sale of medical products in China, announced today its initial public offering of 1,500,000 ordinary shares at $8.00 per share. The ordinary shares will begin trading today under the ticker symbol "DHRM" on the Nasdaq Capital Market.Thu, 22 Apr 2010 12:00:00 AM GMThttp://www.streetinsider.com/IPOs/DynaVox+%28DVOX%29+Sees+IPO+Price+of+$15+-+$17Share/5515069.htmlReuters -- DynaVox Inc said it expects proceeds of up to $150 million from its initial public offering of Class A common shares. The Delaware-based company expects to offer 9.4 million shares at $15 to $17 apiece.Fri, 09 Apr 2010 12:00:00 AM GMThttp://www.businesswire.com/portal/site/biospace/index.jsp?ndmViewId=news_view&newsId=20080926005086&newsLang=enSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced that due to the historic instability in the market, the company is withdrawing its registration statement for its initial public offering of shares of common stock.Fri, 26 Sep 2008 12:00:00 AM GMT